Clinical trials: New-onset Atrial Fibrillation (NOAF)

Atrial Fibrillation

Pharmacological Intervention to Prevent NOAF After TAVR

• Not yet recruiting
• Age: All ages

The goal of this clinical trial is to learn if amiodarone or metoprolol works to prevent new-onset atrial fibrillation (AF) in patients who develop certain atrial arrhythmias after transcatheter aortic valve replacement (TAVR).

Trial name

NCT07519161

Testing

Metoprolol succinate, Amiodarone

Volunteers

198 people

Sponsor

Shanghai East Hospital